| Panitumumab studied in …STUDIED_INderived182 of 182show fewer |
|---|
| → studied in | NCT05564377Phase 2 · recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial · 182 trials list this drug (35 active) | — | — | Malignant Solid Neoplasm,Primary Peritoneal Carcinoma,Malignant Female Reproductive System Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07659795Phase 2 · recruiting A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06820463Phase 2 · recruiting A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05863195Phase 3 · recruiting Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial · 182 trials list this drug (35 active) | — | — | Colorectal Neoplasm,Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05786924Phase 1/Phase 2 · recruiting Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies · 182 trials list this drug (35 active) | — | — | Solid Neoplasm,Histiocytic and Dendritic Cell Neoplasm,Malignant Lung Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05845450Phase 2 · recruiting Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN) · 182 trials list this drug (35 active) | — | — | Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06252649Phase 3 · recruiting Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03366155Phase 2 · completed Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver · 182 trials list this drug (35 active) | — | — | Colorectal Adenocarcinoma,Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04787341Phase 2 · completed PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04034173Phase 2 · terminated Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation · 182 trials list this drug (35 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05423197Phase 2 · withdrawn 89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC · 182 trials list this drug (35 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07094113Phase 1 · recruiting AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors · 182 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07172919Phase 2 · recruiting A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation · 182 trials list this drug (35 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05198934Phase 3 · completed Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03087071Phase 2 · active not recruiting Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03510208Phase 1/Phase 2 · recruiting Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery · 182 trials list this drug (35 active) | — | — | Malignant Glioma,Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07318389early Phase 1 · not yet recruiting ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04587128Phase 2 · active not recruiting Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06314997Phase 2 · recruiting Dynamic Changes in Circulating Tumour Cells Protein Expression · 182 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06998940Phase 3 · recruiting Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · 182 trials list this drug (35 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07094204Phase 1 · recruiting A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors · 182 trials list this drug (35 active) | — | — | Solid Neoplasm,Lung Non-Small Cell Carcinoma,Malignant Colorectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05638295Phase 2 · active not recruiting Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial) · 182 trials list this drug (35 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05694936Phase 2 · active not recruiting Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05747625Phase 1 · recruiting (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma · 182 trials list this drug (35 active) | — | — | Head and Neck Squamous Cell Carcinoma,Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07543744Phase 1 · recruiting A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02876107Phase 2 · active not recruiting Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer · 182 trials list this drug (35 active) | — | — | Breast Carcinoma,Invasive Breast Carcinoma,Breast Inflammatory Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03384238Phase 1/Phase 2 · recruiting Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery · 182 trials list this drug (35 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05901545Phase 1 · recruiting Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer · 182 trials list this drug (35 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06268015Phase 2 · active not recruiting Botensilimab and Balstilimab Optimization in Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04163952Phase 1 · terminated Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin · 182 trials list this drug (35 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03983993Phase 2 · active not recruiting Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm,Microsatellite Stable Colorectal Carcinoma,MSI-H Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06332079Phase 2 · terminated Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients · 182 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06714357Phase 2 · recruiting ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06245356Phase 2 · recruiting Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02593175Phase 2 · completed Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC · 182 trials list this drug (35 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04185883Phase 1 · active not recruiting Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) · 182 trials list this drug (35 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01312857Phase 2 · completed Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06490536Phase 3 · recruiting The Sagittarius Trial · 182 trials list this drug (35 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02885753Phase 3 · recruiting Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver · 182 trials list this drug (35 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03442569Phase 2 · completed PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC · 182 trials list this drug (35 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03186326Phase 2 · completed Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06194877Phase 1 · terminated A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01814501Phase 2 · completed Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab · 182 trials list this drug (35 active) | — | — | Colon Mucinous Adenocarcinoma,Malignant Colon Neoplasm,Malignant Rectal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05121038Phase 1/Phase 2 · active not recruiting CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab · 182 trials list this drug (35 active) | — | — | Pancreatic Carcinoma,Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05177796Phase 2 · withdrawn Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer · 182 trials list this drug (35 active) | — | — | Invasive Breast Carcinoma,Breast Inflammatory Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03635021Phase 3 · active not recruiting Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04117945Phase 2 · active not recruiting Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03263429Phase 1/Phase 2 · completed Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm,RAS Wild-Type Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05084859Phase 1 · terminated A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors · 182 trials list this drug (35 active) | — | — | Lung Non-Small Cell Carcinoma,Malignant Colorectal Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00788957Phase 1/Phase 2 · completed Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC) · 182 trials list this drug (35 active) | — | — | Malignant Digestive System Neoplasm,Malignant Colorectal Neoplasm,Malignant Colon Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06509126Phase 3 · recruiting Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00891930Phase 2 · completed Study to Evaluate Mechanisms of Acquired Resistance to Panitumumab · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01581840Phase 1/Phase 2 · completed Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus · 182 trials list this drug (35 active) | — | — | Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03992456Phase 2 · unknown Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Colorectal Carcinoma,Malignant Colorectal Neoplasm,Colon Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03043950completed Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE) · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05468892Phase 2 · completed Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO Trial · 182 trials list this drug (35 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02925234Phase 2 · recruiting The Drug Rediscovery Protocol (DRUP Trial) · 182 trials list this drug (35 active) | — | — | Neoplasm,Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01776307Phase 2 · completed A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01307956Phase 2 · terminated Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer · 182 trials list this drug (35 active) | — | — | Malignant Esophageal Neoplasm,Esophageal Adenocarcinoma,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00820248Phase 3 · completed Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer · 182 trials list this drug (35 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01591421Phase 1/Phase 2 · completed P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer. · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01991873Phase 2 · completed Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01036087Phase 2 · completed Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer · 182 trials list this drug (35 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01801904Phase 2 · unknown A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03231722Phase 3 · completed First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00819780Phase 2 · completed PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm,Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089635Phase 2 · completed Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00113763Phase 3 · completed Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00364013Phase 3 · completed PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00446446Phase 2 · completed PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) · 182 trials list this drug (35 active) | — | — | Neoplasm,Malignant Neoplasm,Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00339183Phase 3 · completed Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01001377Phase 3 · completed ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03227926Phase 2 · completed Rechallenge With Panitumumab Driven by RAS Dynamic of Resistance · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00979212Phase 2 · completed Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer · 182 trials list this drug (35 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00389870Phase 3 · completed Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02399943Phase 2 · completed A Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Advanced Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04425239Phase 2 · completed Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03940131Phase 2 · unknown Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFR · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03000374Phase 2 · completed Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery · 182 trials list this drug (35 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01750918Phase 1/Phase 2 · completed BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC) · 182 trials list this drug (35 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02643056Phase 2 · completed Study to Investigate the Efficacy of Panitumumab in Platinum-resistant Advanced Head and Neck Squamous Cancer · 182 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00655499Phase 2 · completed Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03751176Phase 2 · unknown Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal · 182 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03142516Phase 2 · completed FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status · 182 trials list this drug (35 active) | — | — | Colorectal Neoplasm,Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03311750Phase 2 · terminated Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01077999Phase 2 · completed Chemoradiation and Panitumumab for Esophageal Cancer · 182 trials list this drug (35 active) | — | — | Esophageal Neoplasm,Adenocarcinoma,Malignant Esophageal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02818725Phase 3 · completed I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations · 182 trials list this drug (35 active) | — | — | Invasive Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01927341Phase 1/Phase 2 · completed Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02008383Phase 1 · completed Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01443065Phase 2 · completed MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma · 182 trials list this drug (35 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00054574Phase 2 · completed Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer · 182 trials list this drug (35 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03300609Phase 3 · terminated 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab · 182 trials list this drug (35 active) | — | — | Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02904031Phase 2 · unknown Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients · 182 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04342676Phase 3 · completed Lymph Node Ratio and Kras Mutation in R Colon Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01202409Phase 2 · completed CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater · 182 trials list this drug (35 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02301962Phase 4 · unknown Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01128387Phase 1/Phase 2 · terminated Trial of Panitumumab/Cisplatin/Fluorouracil Combined With Radiation in Esophageal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00508404Phase 2 · completed Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03069950Phase 2 · withdrawn Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver · 182 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00647530Phase 2/Phase 3 · unknown Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00940316Phase 2 · completed Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00756444Phase 2 · completed A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck · 182 trials list this drug (35 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00115765Phase 3 · completed PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00418938Phase 2 · completed SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial · 182 trials list this drug (35 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm,Malignant Colon Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454779Phase 2 · completed PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response · 182 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00500760Phase 2 · completed Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer · 182 trials list this drug (35 active) | — | — | Malignant Head and Neck Neoplasm,Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02508077Phase 2 · terminated FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01009983Phase 2 · terminated Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer · 182 trials list this drug (35 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01627379Phase 3 · terminated Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer · 182 trials list this drug (35 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01139138Phase 1/Phase 2 · completed Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Colorectal Neoplasm,Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00798655Phase 2 · completed Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer · 182 trials list this drug (35 active) | — | — | Neoplasm,Head and Neck Neoplasm,Malignant Head and Neck Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01704703Phase 2 · completed Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00842257Phase 2 · completed Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00610948Phase 1 · completed Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment · 182 trials list this drug (35 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02089737completed Panitumumab for Intravenous Infusion 100 mg and 400 mg Special Drug Use Surveillance "Survey on Unresectable, Advanced or Recurrent Colorectal Cancer With Wild-type KRAS Gene" (All-patient Surveillance) · 182 trials list this drug (35 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00550836Phase 2 · completed Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer · 182 trials list this drug (35 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00601627Phase 2 · completed Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery · 182 trials list this drug (35 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01175733Phase 1/Phase 2 · completed Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer · 182 trials list this drug (35 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00547157Phase 2 · completed Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck · 182 trials list this drug (35 active) | — | — | Malignant Neoplasm,Malignant Head and Neck Neoplasm,Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01412957Phase 3 · completed Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01206049Phase 2 · completed Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations · 182 trials list this drug (35 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00513383Phase 1 · completed Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck · 182 trials list this drug (35 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00836277Phase 2 · completed Phase II Study of Irinotecan and Panitumumab · 182 trials list this drug (35 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01508000Phase 2 · terminated Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases · 182 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02476045Phase 2 · unknown Panitumumab-based Maintenance in Patients With RAS Wild-type, Metastatic Colorectal Cancer (Valentino) · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01308840Phase 2 · completed Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer · 182 trials list this drug (35 active) | — | — | Malignant Biliary Tract Neoplasm,Malignant Gallbladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01843452Phase 2 · terminated Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal · 182 trials list this drug (35 active) | — | — | Anal Canal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00658658Phase 1 · completed Panitumumab in Children With Solid Tumors · 182 trials list this drug (35 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01042288Phase 2 · completed Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC · 182 trials list this drug (35 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00973193Phase 2 · terminated Preoperative Panitumumab and Radiotherapy in Rectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00563316Phase 1 · completed Effect of Panitumumab on the Pharmacokinetics of Irinotecan · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00094835Phase 1/Phase 2 · completed Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) · 182 trials list this drug (35 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00757172Phase 2 · completed Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction · 182 trials list this drug (35 active) | — | — | Malignant Esophageal Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00332163Phase 2 · completed Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm,Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00411450Phase 2 · completed Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment · 182 trials list this drug (35 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm,Malignant Colon Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01916109Phase 2 · terminated Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer · 182 trials list this drug (35 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01257360Phase 2 · unknown Panitumumab in Combination With Radiotherapy in Patients With Locally Advanced RAS Wildtype Rectal Cancer (Clinical Stages II and III) · 182 trials list this drug (35 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00984217Phase 2 · withdrawn Trial of Radiotherapy and Panitumumab in Salivary Gland Malignancies · 182 trials list this drug (35 active) | — | — | Pleomorphic Adenoma,Salivary Gland Neoplasm,Skin Mixed Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00853931NA · completed Biomarker - Panitumumab Response With KRAS Wild Type MCC · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01312493Phase 2 · withdrawn Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab · 182 trials list this drug (35 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01296035Phase 2 · terminated Panitumumab and Gemcitabine in Relapsed Ovarian Cancer · 182 trials list this drug (35 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00578071Phase 1/Phase 2 · completed Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01226719Phase 2 · completed FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01108107Phase 2 · completed Neoadjuvant Treatment of Colon Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00894504Phase 2 · completed Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer · 182 trials list this drug (35 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01443377Phase 2 · completed Neoadjuvant Radiochemotherapy Combined With Panitumumab in Locally Advanced KRAS Wild-type Rectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01126112Phase 2 · completed Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01215539Phase 2 · completed Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patients · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01038037Phase 2 · terminated First-Line Chemotherapy and Panitumumab in Advanced Non-Small Cell Lung Cancer · 182 trials list this drug (35 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00879385Phase 1 · completed KRAS Wild-type Metastatic Colorectal Cancer Trial · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01305772Phase 2 · terminated Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN · 182 trials list this drug (35 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01418742Phase 2 · terminated SKIP - A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity Treatment · 182 trials list this drug (35 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00814619Phase 2 · completed Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00933517Phase 2 · completed Assessment of the Efficacy of the Neoadjuvant Combination: "Chemotherapy-Targeted Therapy" in Breast Cancer. · 182 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101907Phase 1 · terminated Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer · 182 trials list this drug (35 active) | — | — | Malignant Esophageal Neoplasm,Malignant Lung Neoplasm,Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00630786Phase 1/Phase 2 · completed Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm,Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083616Phase 2 · completed Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy · 182 trials list this drug (35 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00967655Phase 2 · unknown Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00613730Phase 2 · terminated Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint · 182 trials list this drug (35 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00111761Phase 2 · completed Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01110785Phase 2 · unknown Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01017653Phase 2 · terminated Panitumumab and Irinotecan for Malignant Gliomas · 182 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01388621Phase 2 · unknown Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer · 182 trials list this drug (35 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01172717Phase 2 · withdrawn Study of Panitumumab in the Treatment of Carcinoid Syndrome · 182 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00111774Phase 2 · completed Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma · 182 trials list this drug (35 active) | — | — | Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00425035Phase 2 · completed Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2 · 182 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01088620Phase 2 · suspended Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer · 182 trials list this drug (35 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004879Phase 1 · completed Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer · 182 trials list this drug (35 active) | — | — | Malignant Esophageal Neoplasm,Malignant Lung Neoplasm,Malignant Pancreatic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039273Phase 2 · completed Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00861120Phase 2 · completed Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type · 182 trials list this drug (35 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101894Phase 1 · completed Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384994Phase 2 · unknown Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients · 182 trials list this drug (35 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00792363Phase 2 · completed Irinotecan and Panitumumab as 3rd Line Treatment for mCRC Without KRAS Mutations · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01142414Phase 3 · withdrawn Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence · 182 trials list this drug (35 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00113776Phase 2 · completed Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101920Phase 2 · completed ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) · 182 trials list this drug (35 active) | — | — | Lung Neoplasm,Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01158248Phase 2 · unknown Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer · 182 trials list this drug (35 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00327119Phase 2 · completed Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer · 182 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091806Phase 1 · completed Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors · 182 trials list this drug (35 active) | — | — | Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00425204Phase 2 · completed Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment · 182 trials list this drug (35 active) | — | — | Solid Neoplasm,Lung Non-Small Cell Carcinoma,Malignant Colorectal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00034346Phase 2 · completed ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) · 182 trials list this drug (35 active) | — | — | Lung Neoplasm,Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061126Phase 2 · completed ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body · 182 trials list this drug (35 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |